"Oral sprays may work faster than tablets and "eliminate the requirement for water or for the need to swallow, potentially improving patient convenience and adherence," and that Zolpimist is "bioequivalent" to Ambien tablets."
"Because Zolpimist works rapidly, patients should take it "immediately before bedtime and be prepared to get a full night's sleep (7-8 hours)," states NovaDel's news release.
In my opinion and in reality Zolpimist should have a higher revenue stream right now based on it being as good or even better than Ambien taken in a pill form.
There is no logical reason why Zolpimist can't get at least 75% of the market revenue potential that the pill form of Ambien has right now.
How about Duromist?
Why no talk about Duromist now?
Same concept of a spray instead of pill.
The only "nutjobs" here on this message board are toppedout2000 and his very good friend tallicat.
That total nutjob toppedout likes to post how there was a "huge buy" here or a "huge sell" here when somebody sells only 200 dollars worth of shares. He does that every day.
Sell your shares now toppeyjerk, of course you do not want to, why?